Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Improved process for 1,2-indane carboxylic acids via chiral auxiliaries. Enhances yield and scalability for pharmaceutical intermediate manufacturing.
Discover CN101863805B technology for synthesizing chiral sulfinamide catalysts. Enables cost-effective, scalable production of high-purity pharmaceutical intermediates with superior enantioselectivity.
Advanced catalytic method for paroxetine intermediate synthesis. Enhances optical purity and supply chain reliability for global pharmaceutical manufacturing partners.
Novel preparation method for AHU-377 intermediates ensures high chiral purity and yield. Optimized supply chain for pharmaceutical manufacturing partners seeking reliable production.
Patent CN103319374A details a high-yield asymmetric route for (S)-rivastigmine using Ellman auxiliary, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN108659046B reveals a robust route for tetramethyl spiroindane ligands. Discover cost-effective synthesis and high-purity supply for asymmetric catalysis.
Patent CN104313072A details biocatalytic synthesis yielding high ee. Offers supply chain reliability and cost efficiency for global pharmaceutical manufacturing partners.
Novel 7-step route avoids resolution, offering cost-effective manufacturing of chiral proline derivatives for pharmaceutical intermediates.
Patent CN102850383A details a novel chiral zinc-nitrogen complex enabling efficient asymmetric catalysis for fine chemical manufacturing and supply chain optimization.
Novel organocatalysts for asymmetric epoxidation offering high enantioselectivity without transition metals, ensuring reliable supply chain stability.
Patent CN115404249A reveals a novel enzymatic route for (S)-nicotine intermediates. Discover cost-effective biocatalysis solutions for scalable pharmaceutical manufacturing.
Patent CN107304176A details a mild chiral synthesis route for alpha-fluoro beta-amino acids, offering high optical purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN102477016B reveals asymmetric synthesis for Tapentadol intermediates. Achieve high chiral purity and cost reduction in pharmaceutical manufacturing.
Novel squaramide-catalyzed route for halogenated dihydropyranopyrrolones. High yield, mild conditions, antitumor activity. Ideal for API intermediates.
Patent CN103483256A details a novel synthetic route for (-)-FABA, an oxidized aporphine alkaloid derivative with potent antitumor activity, offering scalable manufacturing solutions.
Patent CN101875666A details a novel asymmetric synthesis route for high-purity Dapoxetine intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN103553941B reveals a novel chiral catalyst route for Levalbuterol, offering high purity and significant supply chain cost reduction advantages.
Patent CN109369631B details a novel enzymatic route for LDHA inhibitor intermediates, offering high ee values and scalable manufacturing for reliable pharmaceutical suppliers.
Novel cobalt-catalyzed Kumada coupling method offers high purity and yield for NSAID intermediates, ensuring supply chain stability.
Novel epoxy ethyl methanol route for Lacosamide. High purity, scalable process. Reliable pharmaceutical intermediates supplier for global supply chains.